Stock GTHR GENETHERA, INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News GeneThera, Inc.

Equities

GTHR

US37185E3062

Market Closed - OTC Markets
Other stock markets
 01:14:13 2024-02-20 pm EST 		5-day change 1st Jan Change
0.000001 USD -99.98% Intraday chart for GeneThera, Inc. -.--% -.--%
2022 GeneThera, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
2022 GeneThera, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
GENETHERA INC - 10-K/A -
AQ
GENETHERA INC : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
AQ
GeneThera, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
CI
GENETHERA INC : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
AQ
GeneThera, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
GENETHERA INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
AQ
GeneThera, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
GENETHERA INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)
AQ
GeneThera, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021
CI
GeneThera, Inc. Auditor Raises 'Going Concern' Doubt
CI
GENETHERA INC : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
AQ
GeneThera, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
CI
GeneThera : Inc. Enters into an exclusive real estate agreement with Cushman & Wakefield related to the ZIDAS project
GL
GeneThera Inc. Enters into an exclusive real estate agreement with Cushman & Wakefield related to the ZIDAS project
CI
GENETHERA INC : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)
AQ
GENETHERA INC : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
AQ
Genethera, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021
CI
GeneThera : Expands Its Operation in the United Kingdom
AQ
GeneThera, Inc. announced a financing transaction
CI
GENETHERA : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. GTHR Stock
  4. News GeneThera, Inc.